These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Anti-arrhythmic and haemodynamic effects of intravenous and oral disopyramide in patients with ventricular arrhythmia. Hulting J; Rosenhamer G J Int Med Res; 1976; 4(1 Suppl):90-5. PubMed ID: 1026537 [No Abstract] [Full Text] [Related]
47. Myocardial depression with disopyramide. Bauman DJ Ann Intern Med; 1981 Mar; 94(3):411-2. PubMed ID: 7224397 [No Abstract] [Full Text] [Related]
48. Disopyramide (Norpace) for ventricular arrhythmias. Med Lett Drugs Ther; 1977 Dec; 19(25):101-2. PubMed ID: 593226 [No Abstract] [Full Text] [Related]
53. Disopyramide in the treatment and prevention of arrhythmias following myocardial infarction. Zainal N; Jennings G; Jones B; Model D; Turner P; Besterman EM; Kidner PH J Int Med Res; 1976; 4(1 Suppl):71-3. PubMed ID: 799982 [No Abstract] [Full Text] [Related]
54. Study of an anti-arrhythmic agent, disopyramide, in delayed action form ('Ritmoforine' Retard). Nauta IL; van de Calseyde JF Curr Med Res Opin; 1981; 7(4):215-26. PubMed ID: 7226872 [TBL] [Abstract][Full Text] [Related]
59. Acute termination of cardiac arrhythmias with intravenous disopyramide. Ee BK; Chia BL; Ng RA; Oh V; Tan AT; Choo M Singapore Med J; 1982 Aug; 23(4):185-90. PubMed ID: 7178900 [No Abstract] [Full Text] [Related]
60. Intravenous and oral disopyramide after myocardial infarction. Nicholls DP; Haybyrne T; Barnes PC Lancet; 1980 Nov; 2(8201):936-8. PubMed ID: 6107587 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]